Waystar Holding Corp. (NASDAQ:WAY - Get Free Report) CEO Matthew Hawkins sold 82,500 shares of the company's stock in a transaction dated Tuesday, October 6th. The shares were sold at an average price of $26.23, for a total value of $2,163,975.00. Following the sale, the chief executive officer owned 1,804,794 shares in the company, valued at approximately $47,339,746.62. The trade was a 4.37% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Waystar Trading Down 2.4%
WAY stock traded down $0.63 during mid-day trading on Wednesday, reaching $25.77. The company's stock had a trading volume of 1,773,022 shares, compared to its average volume of 2,587,997. Waystar Holding Corp. has a 12 month low of $17.26 and a 12 month high of $40.35. The company has a current ratio of 1.85, a quick ratio of 1.85 and a debt-to-equity ratio of 0.36. The business's 50 day moving average price is $24.80 and its 200 day moving average price is $22.78. The company has a market cap of $4.94 billion, a price-to-earnings ratio of 36.81, a price-to-earnings-growth ratio of 1.03 and a beta of 0.18.
Waystar (NASDAQ:WAY - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $0.43 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.40 by $0.03. The firm had revenue of $319.67 million for the quarter, compared to analysts' expectations of $316.21 million. Waystar had a return on equity of 7.03% and a net margin of 11.18%.The company's revenue for the quarter was up 18.1% compared to the same quarter last year. During the same period in the prior year, the business earned $0.36 EPS. On average, equities research analysts predict that Waystar Holding Corp. will post 1.47 EPS for the current year.
Hedge Funds Weigh In On Waystar
Several large investors have recently bought and sold shares of WAY. Jupiter Topco LLC bought a new position in shares of Waystar during the 2nd quarter worth approximately $58,960,000. Clarkston Capital Partners LLC purchased a new stake in shares of Waystar during the first quarter valued at approximately $22,917,000. Bain Capital Venture Investors LLC purchased a new stake in shares of Waystar during the second quarter valued at approximately $18,127,271. Hsbc Holdings PLC bought a new stake in Waystar during the first quarter worth $5,625,000. Finally, Diamond Hill Capital Management LLC Investment Advisor bought a new stake in Waystar during the second quarter worth $43,314,000.
Wall Street Analyst Weigh In
WAY has been the subject of a number of research reports. Morgan Stanley restated an "equal weight" rating and issued a $28.00 price target on shares of Waystar in a report on Wednesday, September 16th. UBS Group reduced their target price on Waystar from $37.00 to $33.00 and set a "buy" rating for the company in a research note on Thursday, July 30th. KeyCorp reaffirmed an "overweight" rating on shares of Waystar in a research note on Friday, July 31st. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $39.00 price objective on shares of Waystar in a research note on Friday, July 31st. Finally, Barclays lowered Waystar from an "overweight" rating to an "equal weight" rating and upped their target price for the stock from $27.00 to $30.00 in a research report on Tuesday, September 15th. Two analysts have rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $34.67.
View Our Latest Stock Report on Waystar
About Waystar
(
Get Free Report)
Waystar Holding Corp. is a healthcare technology company that provides cloud-based software for managing healthcare payments and revenue cycle operations. Its platform connects healthcare providers, payers and patients to help streamline administrative and financial workflows across the healthcare system.
The company's products and services include eligibility and benefits verification, claims management and submission, prior authorization, payment processing, patient billing, denial management and revenue cycle analytics.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Waystar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waystar wasn't on the list.
While Waystar currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.